Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DX25F6XTS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $38,347
Award facts
- Contract value 100% obligated
- $38,346.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $38,346.96 on September 18, 2025, for the supply of Alecensa 150 mg capsules (240 units). The award was issued without a set-aside designation by the Medical Supply Chain division of the Defense Logistics Agency and is scheduled for ultimate completion by October 9, 2025. This delivery order falls under the company's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities nationwide. The company's federal contract portfolio demonstrates its expertise in supplying specialized pharmaceutical products, including oncology medications such as Alecensa, which is used in cancer treatment. By leveraging its woman-owned small business status and established presence in federal procurement markets since 2001, DMS Pharmaceutical Group continues to compete effectively for contracts that support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DX25F6XTS?
SPE2DX25F6XTS was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 18, 2025.
How much is contract SPE2DX25F6XTS worth?
The government has obligated $38,347 on SPE2DX25F6XTS.
Is contract SPE2DX25F6XTS an order under another contract?
Yes. SPE2DX25F6XTS is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTS competed?
The extent of competition for SPE2DX25F6XTS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award